Breaking News Instant updates and real-time market news.

INFN

Infinera

$7.90 /

-0.2 (-2.47%)

20:56
02/25/20
02/25
20:56
02/25/20
20:56

Infinera price target raised to $8.50 from $5.50 at Piper Sandler

Piper Sandler analyst Troy Jensen raised his price target on Infinera to $8.50 after its Q4 earnings beat and with bookings in the quarter exceeding revenues. The analyst further notes that the company has achieved its promise to reach profitability, but also maintains his Neutral rating given the stock's recent outperformance and amid the supply chain concerns.

  • 25

    Feb

  • 09

    Mar

INFN Infinera
$7.90 /

-0.2 (-2.47%)

01/02/20 Needham
Infinera price target raised to $12 from $10 at Needham
12/16/19 Needham
Infinera price target raised to $10 from $9 at Needham
11/13/19
Fly Intel: Top five analyst upgrades
11/13/19 JPMorgan
Infinera upgraded to Neutral on acquisition execution at JPMorgan

TODAY'S FREE FLY STORIES

Upgrade
Sherwin-Williams upgraded to Conviction Buy from Neutral at Goldman Sachs » 05:41
03/30/20
03/30
05:41
03/30/20
05:41
SHW

Sherwin-Williams

$461.17 /

-3.92 (-0.84%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Republic Services upgraded to Overweight from Neutral at JPMorgan » 05:38
03/30/20
03/30
05:38
03/30/20
05:38
RSG

Republic Services

$75.45 /

-2.14 (-2.76%)

JPMorgan analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
ING Group suspends dividend payment due to COVID-19 » 05:35
03/30/20
03/30
05:35
03/30/20
05:35
ING

ING Group

$6.04 /

-0.44 (-6.79%)

ING provided the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Mondelez upgraded to Buy from Hold at Stifel » 05:35
03/30/20
03/30
05:35
03/30/20
05:35
MDLZ

Mondelez

$47.61 /

-0.93 (-1.92%)

Stifel analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Regeneron, Sanofi announce first patient outside U.S. treated in Kevzara study » 05:33
03/30/20
03/30
05:33
03/30/20
05:33
REGN

Regeneron

$448.05 /

-4.26 (-0.94%)

, SNY

Sanofi

$42.47 /

-0.48 (-1.12%)

Regeneron Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
GFL Environmental initiated with a Buy at Stifel » 05:31
03/30/20
03/30
05:31
03/30/20
05:31
GFL

GFL Environmental

$14.95 /

-0.09 (-0.60%)

Stifel analyst Michael…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Carbo Ceramics to be acquired by Wilks Brothers » 05:30
03/30/20
03/30
05:30
03/30/20
05:30
CRR

Carbo Ceramics

$0.00 /

+ (+0.00%)

CARBO Ceramics announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Upgrade
Magellan Midstream upgraded to Buy from Underperform at BofA » 05:29
03/30/20
03/30
05:29
03/30/20
05:29
MMP

Magellan Midstream

$33.53 /

-0.92 (-2.67%)

BofA analyst Derek Walker…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
International Paper agrees to sell Brazilian corrugated packaging business » 05:28
03/30/20
03/30
05:28
03/30/20
05:28
IP

International Paper

$30.60 /

-0.45 (-1.45%)

International Paper has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Moderna provides update on COVID-19 impact » 05:27
03/30/20
03/30
05:27
03/30/20
05:27
MRNA

Moderna

$30.01 /

+2.1 (+7.52%)

Moderna provided an…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Polaris Industries downgraded to Market Perform from Outperform at BMO Capital » 05:26
03/30/20
03/30
05:26
03/30/20
05:26
PII

Polaris Industries

$47.25 /

-5.545 (-10.50%)

BMO Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
NeoPhotonics upgraded to Overweight from Neutral at Piper Sandler » 05:23
03/30/20
03/30
05:23
03/30/20
05:23
NPTN

NeoPhotonics

$6.72 /

-0.045 (-0.67%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
AstraZeneca says FARXIGA reduced incidence of heart failure worsening » 05:23
03/30/20
03/30
05:23
03/30/20
05:23
AZN

AstraZeneca

$42.56 /

+0.26 (+0.61%)

New data from a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Cleveland-Cliffs reinstated with a Neutral at Goldman Sachs » 05:20
03/30/20
03/30
05:20
03/30/20
05:20
CLF

Cleveland-Cliffs

$3.79 /

-0.1 (-2.57%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Stelco Holdings downgraded to Sell from Neutral at Goldman Sachs » 05:18
03/30/20
03/30
05:18
03/30/20
05:18
STZHF

Stelco Holdings

$0.00 /

+ (+0.00%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Reliance Steel upgraded to Buy from Neutral at Goldman Sachs » 05:16
03/30/20
03/30
05:16
03/30/20
05:16
RS

Reliance Steel

$83.41 /

-8.04 (-8.79%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Nucor upgraded to Buy from Neutral at Goldman Sachs » 05:15
03/30/20
03/30
05:15
03/30/20
05:15
NUE

Nucor

$32.95 /

-0.3 (-0.90%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Nektar upgraded to Neutral from Sell at Goldman Sachs » 05:09
03/30/20
03/30
05:09
03/30/20
05:09
NKTR

Nektar

$17.26 /

-0.25 (-1.43%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Hermes upgraded to Neutral from Sell at Goldman Sachs » 05:07
03/30/20
03/30
05:07
03/30/20
05:07
HESAY

Hermes

$0.00 /

+ (+0.00%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Syneos Health downgraded to Neutral from Buy at Goldman Sachs » 05:04
03/30/20
03/30
05:04
03/30/20
05:04
SYNH

Syneos Health

$41.41 /

-2.51 (-5.71%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Atco upgraded to Outperform from Market Perform at BMO Capital » 05:00
03/30/20
03/30
05:00
03/30/20
05:00
ACLLF

Atco

$0.00 /

+ (+0.00%)

BMO Capital analyst Ben…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Upgrade
Fortis upgraded to Outperform from Market Perform at BMO Capital » 04:58
03/30/20
03/30
04:58
03/30/20
04:58
FTS

Fortis

$35.52 /

-1.2 (-3.27%)

BMO Capital analyst Ben…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Emera upgraded to Outperform from Market Perform at BMO Capital » 04:56
03/30/20
03/30
04:56
03/30/20
04:56
EMRAF

Emera

$0.00 /

+ (+0.00%)

BMO Capital analyst Ben…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Hydro One upgraded to Outperform from Market Perform at BMO Capital » 04:55
03/30/20
03/30
04:55
03/30/20
04:55
HRNNF

Hydro One

$0.00 /

+ (+0.00%)

BMO Capital analyst Ben…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Oyster Point Pharma participates in a conference call with JPMorgan » 04:55
03/30/20
03/30
04:55
03/30/20
04:55
OYST

Oyster Point Pharma

$35.14 /

-0.21 (-0.59%)

SMid Biotech Analyst Rama…

SMid Biotech Analyst Rama holds a conference call with CEO Nau on March 30 at 11 am hosted by JPMorgan.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.